Announce Date | 02/27/2025 |
EPS Normalized Actual | $1.05 (Miss by $-0.28) |
EPS GAAP Actual | $1.05 (Miss by $-0.28) |
Revenue Actual | $0.39758B |
Revenue Surprise | Beat by $397.58M |
Announce Date | 05/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.0875 |
EPS GAAP Estimate | $2.0875 |
Revenue Estimate | $0.4680065B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2027 | 10.27 | 5.71 | 10.21753 | 10.34947 | 1 |
Apr 2026 | 8.335 | 7.03 | 7.99951 | 8.68876 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.1 | -0.45913 | 0.39758B | -6.17% | -7.15M |
FQ4 2024 (Oct 2024) | 1.81 | -0.84818 | 0.452482B | -4.73% | -36.48M |
FQ3 2024 (Jul 2024) | 1.91 | 1.91 | 0.459128B | -8.52% | 459.13M |
FQ2 2024 (Apr 2024) | 0 | 0 | 0.453278B | -6.14% | 453.28M |
FQ1 2024 (Jan 2024) | 1.32 | 1.32 | 0.422102B | -13.89% | 422.1M |
FQ4 2023 (Oct 2023) | 1.86 | 1.86 | 0.473867B | -18.49% | 473.87M |
FQ3 2023 (Jul 2023) | 2.3 | 2.3 | 0.498255B | -8.96% | 498.26M |
FQ2 2023 (Apr 2023) | 1.81 | 1.81 | 0.481095B | 100% | 481.1M |
FQ4 Announce Date
05/01/2025 (Pre-Market)
Consensus EPS Estimates
2.0875
Consensus Revenue Estimates
0.4680065B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 1.405 | -- | 1.36939 | 1.45563 | 1 |
FQ4 2026 (Oct 2026) | 2.495 | -- | 2.43177 | 2.58491 | 1 |
FQ3 2026 (Jul 2026) | 2.33 | -- | 2.27095 | 2.41396 | 1 |
FQ2 2026 (May 2026) | 2.64667 | -- | 2.57128 | 2.7164 | 1 |
FQ1 2026 (Jan 2026) | 2.09 | 47.37 | 2.07999 | 2.1005 | 0 |
FQ4 2025 (Oct 2025) | 3.065 | 40.95 | 2.96476 | 3.19859 | 2 |
FQ3 2025 (Jul 2025) | 3 | 36.33 | 2.90188 | 3.13076 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 0.43B | -- | 0.42B | 0.44B | 2 |
FQ4 2026 (Oct 2026) | 0.47B | -- | 0.46B | 0.49B | 2 |
FQ3 2026 (Jul 2026) | 0.46B | -- | 0.45B | 0.47B | 2 |
FQ2 2026 (May 2026) | 0.49B | -- | 0.48B | 0.5B | 2 |
FQ1 2026 (Jan 2026) | 0.47B | 14.56 | 0.46B | 0.47B | 0 |
FQ4 2025 (Oct 2025) | 0.51B | 10.51 | 0.49B | 0.52B | 0 |
FQ3 2025 (Jul 2025) | 0.51B | 9.57 | 0.49B | 0.52B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.55913 | 1.1 | -0.45913 | -41.74% |
FQ4 2024 (Oct 2024) | 2.65818 | 1.81 | -0.84818 | -46.86% |
FQ3 2024 (Jul 2024) | 1.91 | 1.91 | 100% | |
FQ2 2024 (Apr 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Jan 2024) | 1.32 | 1.32 | 100% | |
FQ4 2023 (Oct 2023) | 1.86 | 1.86 | 100% | |
FQ3 2023 (Jul 2023) | 2.3 | 2.3 | 100% | |
FQ2 2023 (Apr 2023) | 1.81 | 1.81 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0.4B | $0.4B | $-7.15M | -1.8% |
FQ4 2024 (Oct 2024) | $0.49B | $0.45B | $-36.48M | -8.06% |
FQ3 2024 (Jul 2024) | $0B | $0.46B | $459.13M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.45B | $453.28M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.42B | $422.1M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.47B | $473.87M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.5B | $498.26M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.48B | $481.1M | 100% |